Gastric protection by nocloprost against aspirin damage in humans. Possible role of epidermal growth factor.
暂无分享,去创建一个
J. Konturek | I. Amon | Z. Hebzda | S. Konturek | N. Kwiecień | W. Obtułowicz | J. Oleksy
[1] T. Brzozowski,et al. Nocloprost, a unique PGE2 analog, with local gastroprotective and ulcer healing activity. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.
[2] Konturek Sj. Role of growth factors in gastroduodenal protection and healing of peptic ulcers. , 1990 .
[3] S. Grundy,et al. Effects of aspirin on gastric mucosal prostaglandin E2 and F2 alpha content and on gastric mucosal injury in humans receiving fish oil or olive oil. , 1990, Gastroenterology.
[4] S. Konturek,et al. Effects of an antral mucosectomy, L-364,718 and atropine on cephalic phase of gastric and pancreatic secretion in dogs. , 1990, Gastroenterology.
[5] J. Konturek,et al. Distribution and release of epidermal growth factor in man. , 1989, Gut.
[6] S. Roth,et al. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation. , 1987, Archives of internal medicine.
[7] J. Rousseau,et al. ACUTE TRANSVERSE MYELITIS AS PRESENTING NEUROLOGICAL FEATURE OF LYME DISEASE , 1986, The Lancet.
[8] M. Ligumsky,et al. Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. , 1986, Gastroenterology.
[9] M. M. Cohen,et al. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study. , 1985, Gastroenterology.
[10] T. Miller. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. , 1983, The American journal of physiology.
[11] M. Ligumsky,et al. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat , 1983 .
[12] M. Polanski,et al. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. , 1983, Gut.
[13] M. M. Cohen,et al. Mechanism of aspirin injury to human gastroduodenal mucosa. , 1982, Prostaglandins, leukotrienes, and medicine.
[14] A. Dembińska-kieć,et al. Gastric cytoprotection by epidermal growth factor: Role of endogenous prostaglandins and DNA synthesis , 1981 .
[15] E. Sito,et al. Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol. , 1981, Gut.
[16] R. Nelson,et al. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. , 1980, The New England journal of medicine.
[17] J. N. Hunt,et al. Aspirin-induced gastric bleeding stops despite rising plasma salicylate , 1980, Digestive diseases and sciences.
[18] R. Gatti,et al. HLA-D locus typing in ankylosing spondylitis and Reiter's syndrome. , 1979, Arthritis and rheumatism.
[19] S. Chernish,et al. Comparison of gastrointestinal effects of aspirin and fenoprofen. A double blind crossover study. , 1979, Arthritis and rheumatism.
[20] R. Craig,et al. Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. , 1977, JAMA.
[21] A. R. Cooke. The role of acid in the pathogenesis of aspirin-induced gastrointestinal erosions and hemorrhage , 1973, The American journal of digestive diseases.
[22] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.
[23] A. Saltzman. Fluorophotometric method for the estimation of salicylate in blood. , 1948, The Journal of biological chemistry.
[24] A. H. Douthwaite,et al. GASTROSCOPIC OBSERVATION OF THE EFFECT OF ASPIRIN AND CERTAIN OTHER SUBSTANCES ON THE STOMACH , 1938 .